Home › Blood Disorders › District of Columbia
Blood Disorders clinical trials in District of Columbia
4 studies for Blood Disorders are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Childrens National Hospital, Washington D.C.
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Sep 28, 2026 · NCT06439082A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.